Comparison of fludarabine/melphalan(flumel) with fludarabine/melphalan/bcnu or thiotepa(fbm/ftm) in patients with AML undergoing allogeneic hematopoietic cell transplantation - a registry study on behalf of the ebmt alwp
Duque-Afonso, J. Finke, J. Ngoya, M. Labopin, M. Nicholson, E. Kottaridis, P. Craddock, C. Tholouli, E. Protheroe, R. Wagner-Drouet, E. M.
Duque-Afonso, J.
Finke, J.
Ngoya, M.
Labopin, M.
Nicholson, E.
Kottaridis, P.
Craddock, C.
Tholouli, E.
Protheroe, R.
Wagner-Drouet, E. M.
Citations
Altmetric:
Abstract
Description
Date
2022
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Duque-Afonso J, Finke J, Ngoya M, Labopin M, Nicholson E, Kottaridis P, et al. Comparison of fludarabine/melphalan(flumel) with fludarabine/melphalan/bcnu or thiotepa(fbm/ftm) in patients with AML undergoing allogeneic hematopoietic cell transplantation - a registry study on behalf of the ebmt alwp. Bone marrow transplantation. 2022 Nov;57(SUPPL 1):164-5. PubMed PMID: WOS:000878153300253.